Businesses Appeal £100M CMA Fine For Overpriced Drug
Drugmaker Advanz and two other companies have appealed against a £100 million ($134 million) fine from Britain's antitrust watchdog for inflating the price of tablets for thyroid conditions by 1,110%....To view the full article, register now.
Already a subscriber? Click here to view full article